We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Learn more here.Close Me
President Donald Trump has signed an executive order that commits the Department of
Health and Human Services (HHS) to taking a series of regulatory
and subregulatory actions intended to enhance the fiscal
sustainability of the Medicare program, reduce regulatory burdens
on providers, and increase beneficiary choice. The planned
initiatives, which would require further policy development and
potentially statutory changes, generally are in line with
market-based themes the Administration has emphasized previously.
The President also used the Executive Order to slam proposed
"Medicare for All" legislation, which the Administration
claims would "destroy our current Medicare program."
In particular, the executive order provides that within one
year, the HHS Secretary must propose regulations to:
Provide Medicare beneficiaries with diverse and affordable plan
choices by: encouraging innovative MA benefit structures and plan
designs (including allowing beneficiaries to share in cost
savings); reducing barriers to obtaining Medicare Medical Savings
Accounts; promoting supplemental benefit; and encouraging
telehealth innovations.
Adjust MA plan network adequacy requirements to account for
state health market competitiveness and access to telehealth
services and other innovative technologies.
Eliminate rules that burden providers, create inefficiencies,
or undermine patient outcomes. More specifically, HHS should
eliminate burdensome billing requirements, conditions of
participation, supervision requirements, benefit definitions, and
Medicare licensure requirements that exceed statutory
mandates.
Ensure appropriate Medicare reimbursement to primary and
specialist health providers for time spent with patients and, to
the extent allowed by law, reimburse clinicians based on work
performed rather than the clinician's occupation.
Streamline the approval, coverage, and coding processes to
bring innovative products to market faster with appropriate
reimbursement. This should include minimizing steps between Food
& Drug Administration (FDA) approval and Centers for Medicare
& Medicaid Services (CMS) coverage decisions; facilitating
parallel FDA and CMS review; and clarifying Medicare coverage
standards. CMS also should modify the Value-Based Insurance
Design payment model to remove disincentives to MA coverage of new
technologies.
Improve the availability of quality and cost data to enable
seniors to make better health care decisions and hold providers and
plans accountable.
In addition to these regulatory mandates, the executive order
directs HHS to:
Study how Medicare FFS payments could be modified to more
closely reflect the prices paid by MA and commercial plans.
Separately, the Secretary must study "approaches to transition
toward true market-based pricing in the FFS Medicare program,"
including through: shared savings and competitive bidding in
FFS Medicare; use of MA-negotiated rates to set FFS Medicare rates;
and novel approaches to information development and sharing to
enable markets to lower cost and improve quality for FFS Medicare
beneficiaries. Note that changes to the fundamental structure
of Medicare FFS payments to providers (outside of an Innovation
Center or other demonstration program) could require statutory
changes.
Identify and remove unnecessary barriers to private contracts
that allow Medicare beneficiaries to obtain the care of their
choice and facilitate market-driven prices.
Ensure that Medicare policies promote site neutrality.
Use claims data to inform providers about practice patterns
that may pose undue patient risks, are outliers, or are outside
recommended standards of care.
Revise policies to preserve Social Security retirement benefits
for seniors who choose not to receive Medicare Part A benefits, and
propose administrative improvements to the Medicare beneficiary
enrollment process.
The executive order also calls on HHS to enact policies to
combat Medicare fraud, waste, and abuse, "including through
the use of the latest technologies such as artificial
intelligence." Citing the executive order, on October 21,
2019, CMS released a request for information (RFI) on "Using Advanced Technology in Program
Integrity," seeking "innovative, but fiscally prudent
and operationally feasible, ways to conduct program integrity more
effectively and efficiently." Among other things, the
RFI requests comments on the potential impact of artificial
intelligence medical record review technologies in reducing the
burden of medical review; how to incorporate documentation
requirement repositories; how to improve provider enrollment; and
how to improve data analytic and data system capabilities.
Comments will be accepted until November 20, 2019.
This article is presented for informational purposes only
and is not intended to constitute legal advice.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.